How Anastrozole Works
Anastrozole is a selective, non-steroidal aromatase inhibitor that blocks the conversion of adrenal androgens (primarily androstenedione and testosterone) to estrogens (estrone and estradiol) in peripheral tissues, thereby suppressing estrogen biosynthesis in postmenopausal women. 1
Mechanism of Action
Anastrozole works by specifically inhibiting the aromatase enzyme, which is the key enzyme responsible for estrogen production in postmenopausal women. Since many breast cancers are stimulated or maintained by estrogens, blocking this enzyme effectively starves hormone-dependent tumors of their growth stimulus 1.
Pharmacologic Effects
- Estrogen Suppression: Anastrozole 1 mg daily reduces serum estradiol by approximately 70% within 24 hours and by approximately 80% after 14 days of treatment, lowering estradiol to the lower limit of detection (3.7 pmol/L) 1
- Selectivity: The drug has no detectable effect on formation of adrenal corticosteroids, aldosterone, thyroid function, or other steroid hormones, making it highly selective for aromatase 1
- Duration of Effect: Suppression of serum estradiol is maintained for up to 6 days after stopping the medication 1
Clinical Context
Anastrozole only works in postmenopausal women because aromatization of adrenal androgens is not a significant source of estradiol in premenopausal women 2. In premenopausal women, the ovaries are the primary source of estrogen, so anastrozole would not be expected to lower estradiol levels effectively 1.
Approved Uses
The drug is used for:
- Breast cancer risk reduction in high-risk postmenopausal women (1 mg daily for 5 years) 2
- Treatment of hormone receptor-positive breast cancer in postmenopausal women 1
The IBIS-II trial demonstrated that anastrozole reduces the risk of estrogen receptor-positive breast cancers by approximately 58% (HR 0.42; 95% CI, 0.25-0.71) in postmenopausal women at increased risk 2.
Important Clinical Considerations
Key side effects relate directly to estrogen suppression: bone loss and increased fracture risk, musculoskeletal symptoms (joint stiffness, arthralgia), vasomotor symptoms (hot flashes), and cardiovascular considerations 2. These effects occur because estrogen plays protective roles in bone metabolism and cardiovascular health that are lost when the drug blocks estrogen production.